Laarne, Belgium

Rudy Jean Marc Mortier

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Virco N.v.. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rudy Jean Marc Mortier. Retrieved from https://idiyas.com/inventor/rudy-jean-marc-mortier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Rudy Jean Marc Mortier

Introduction

Rudy Jean Marc Mortier is a notable inventor based in Laarne, Belgium. He has made significant contributions to the field of drug resistance measurement through his innovative methods. His work focuses on correlating genotypic information with phenotypic profiles to enhance therapeutic strategies.

Latest Patents

Rudy holds a patent titled "Methods for measuring therapy resistance." This invention addresses the critical issue of drug resistance by providing methods to interpret genotypic information. The process involves generating a genetic code from a patient sample, identifying mutations related to drug resistance, and utilizing databases to determine the mean change in inhibition for specific drugs.

Career Highlights

Rudy is associated with Virco N.V., where he applies his expertise in developing methods that can significantly impact patient treatment outcomes. His work is pivotal in advancing personalized medicine and improving therapeutic efficacy.

Collaborations

Rudy collaborates with esteemed colleagues such as Brendan Larder and Stuart Bloor, contributing to a dynamic research environment that fosters innovation.

Conclusion

Rudy Jean Marc Mortier's contributions to measuring therapy resistance exemplify the intersection of genetics and pharmacology. His innovative methods are set to enhance the understanding and treatment of drug resistance, ultimately benefiting patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…